TNR Diagnostics is a life sciences start-up which is focused on providing accurate and user-friendly in vitro tests for the rapid screening and characterization of genetic repeat disorders. The tests are based on innovative diagnostic solutions developed at the National University of Singapore (NUS). As an incubatee of The Biofactory, TNR Diagnostics was able to accelerate the development and launch of these novel in-vitro diagnostic kits.
TNR Diagnostics is currently developing FastFraX IVD kits for first-line screening and diagnosis of Fragile X Syndrome. The company is also exploring solutions for the screening and diagnosis of other genetic repeat disorders such as Huntington’s Disease and Myotonic Dystrophy Type 1.